Dengue Vaccine Shows Favorable Safety Profile in Travelers From Non-Endemic Regions
4 Articles
4 Articles
New data confirms dengue vaccine safety for older and chronic-risk travelers
Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.
Dengue vaccine shows favorable safety profile in travelers from non-endemic regions
Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic. The findings come from a study led by the Barcelona Institute for Global Health, together with Hospital Clínic Barcelona, and published in The Lancet Regional Health Europe.
The follow-up of the participants did not reveal serious adverse events, while the reported reactions were mostly mild or moderate and less frequent after the second dose. Dengue is a viral disease transmitted by mosquitoes of the genus Aedes. Its transmission has been documented in more than 100 countries, and it is estimated that more than half of the world’s population lives in areas at risk of infection. In recent decades, the incidence of d…
A new study led by the Institute of Global Health (ISGlobal) points out that the TAK-003 dengue vaccine shows a favorable safety profile in traveling people from non-endemic regions.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
